Mice, shrews are most effective at transferring Lyme disease and anaplasmosis

NewsGuard 100/100 Score

Mice and shrews most effective at transferring Lyme disease and other pathogens to feeding ticks

In the U.S., some 300,000 people are diagnosed with Lyme disease annually. Thousands also suffer from babesiosis and anaplasmosis, tick-borne ailments that can occur alone or as co-infections with Lyme disease. According to a new paper published in PLOS ONE, when small, fast-living mammals abound, so too does our risk of getting sick.

In eastern and central North America, blacklegged ticks are the primary vectors for Lyme disease, babesiosis, and anaplasmosis. The pathogens that cause these illnesses are widespread in nature; ticks acquire them when they feed on infected animals.

Richard S. Ostfeld, the paper's lead author and a scientist at the Cary Institute of Ecosystem Studies, has researched the ecology of Lyme disease since 1992. "A pattern emerged in our long-term studies. Ticks that fed on certain rodents and shrews were much more likely to pick up multiple pathogens, making the environment riskier for people."

To investigate why mammals differ in their 'reservoir competence' or ability to transmit pathogens to ticks, Ostfeld and his co-authors from Bard College, Oregon State University, the University of South Florida, and EcoHealth Alliance took a two-pronged approach.

First, they looked at life history traits for nine mammals known to harbor Lyme disease, babesiosis, and anaplasmosis. Attributes like body size, litter size, and life span were taken into consideration.

Then they looked at the role of mammal population density. As 'sit and wait' parasites, ticks are much more likely to encounter animals with dense populations. This, in turn, could help pathogens evolve to exploit specific hosts, resulting in more effective transmission rates.

For Lyme disease and anaplasmosis, fast life history features were a strong predictor of an animal's ability to transmit infection to ticks. Body size was inversely related to reservoir competence. Raccoon, skunk, opossum, squirrel, and deer infected fewer ticks than their mouse, chipmunk, and shrew counterparts.

Ostfeld notes, "This is consistent with past research on Lyme disease, West Nile virus, and Eastern Equine encephalitis. There is evidence that animals that mature early and have frequent, large litters invest less in some immune defenses, making them better pathogen hosts."

Population density was the best predictor of species' abilities to transmit all three pathogen groups, with animals that ticks encountered most frequently being the most effective at transferring infection. Co-author Felicia Keesing of Bard College explains, "Fast life history and high population density often go hand-in-hand. In rodents and shrews, pathogen adaptation and poor immune defense may be working together to amplify disease spread."

With Ostfeld concluding, "In our struggle to manage the ever-growing list of tick-borne diseases, we need to understand which animals magnify human disease risk. Our results suggest when generalist pathogens emerge, small mammals with large populations and a fast pace of life warrant careful monitoring."

Source: Cary Institute of Ecosystem Studies

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine